Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1, First-In-Human, Single and Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Clinical Efficacy of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC).
The goal of this clinical trial is to determine safety, tolerability, pharmacokinetics, preliminary efficacy, and Maximum Tolerable Dose (MTD), of intralesiona…
Nodular Basal Cell Carcinoma
Estimated
~$10 – $8,750
Feldan TherapeuticsNCT07670858
Phase 1
An Open-Label Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
This study will be a multicenter, prospective, open label, one-arm study intended to assess the Safety and Efficacy of EscharEx (EX-02) in the treatment of Bas…
Superficial Basal Cell CarcinomaNodular Basal Cell Carcinoma
Estimated
~$10 – $8,750
MediWound LtdNCT05157763